PRESS RELEASE published on 03/10/2026 at 06:40, 7 months 27 days ago Galenica achieves strong annual result and increases mid-term guidance Galenica achieves strong annual results, increasing sales by 5.5% to CHF 4,135.6 million in 2025. Mid-term EBIT guidance raised to CHF 270 million by 2027 Sales Increase Annual Results EBIT Growth Galenica Mid-term Guidance
BRIEF published on 02/24/2026 at 06:45, 8 months 10 days ago Galenica is repositioning its subsidiary Bichsel towards home healthcare Home Care Galenica Social Plan Bichsel Production Closed
BRIEF published on 02/24/2026 at 06:45, 8 months 10 days ago Galenica Restructures Bichsel with Focus on Home Care Services Home Care Services Galenica AG Bichsel Restructuring Job Impact Financial Effects
PRESS RELEASE published on 02/24/2026 at 06:40, 8 months 10 days ago Galenica focuses Bichsel’s business on home care services Galenica's subsidiary Bichsel to focus on home care services and discontinue pharmaceutical production by end of 2026, affecting 170 jobs. Galenica strengthens strategy implementation Galenica Pharmaceutical Production Home Care Services Strategy Implementation Bichsel
BRIEF published on 01/22/2026 at 06:45, 9 months 15 days ago Galenica: Historic growth despite a challenging market Dividend Growth Diagnostics Pharmacies Logistics & IT
BRIEF published on 01/22/2026 at 06:45, 9 months 15 days ago Galenica AG Sees Record Sales Growth to Over CHF 4 Billion Financial Performance Sales Growth Galenica Pharmacy Expansion Diagnostics Introduction
PRESS RELEASE published on 01/22/2026 at 06:40, 9 months 15 days ago Galenica continues to grow: sales increase to over CHF 4 billion Galenica reports sales growth to over CHF 4 billion in 2025, driven by strong demand for prescription drugs and new 'Diagnostics' area. EBIT guidance and dividend expectations confirmed Sales Growth Galenica Diagnostics Prescription Drugs CHF 4 Billion
BRIEF published on 12/16/2025 at 14:00, 10 months 20 days ago Galenica expands its digital presence with the acquisition of Puravita Acquisition DIGITAL Galenica Puravita Drugstores
BRIEF published on 12/16/2025 at 14:00, 10 months 20 days ago Galenica Expands Digital Footprint with Puravita Acquisition Galenica Pharmacy Market Digital Expansion Puravita Online Offering
BRIEF published on 11/10/2025 at 18:00, 11 months 25 days ago Galenica Successfully Places CHF 250 Million Bond Long-term Financing SIX Swiss Exchange Bond Placement Galenica AG CHF 250 Million
Published on 11/06/2026 at 05:15, 5 hours 28 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 00:53, 9 hours 50 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 9 hours 58 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/06/2026 at 10:28, 15 minutes ago Tradegate BSX continues to expand its reach in the German retail investor market
Published on 11/06/2026 at 10:15, 28 minutes ago Marco Fuchs Receives EY Entrepreneur Of The Year 2026 Award
Published on 11/06/2026 at 10:05, 38 minutes ago Smart City Expo 2026 closes after showing the real impact of urban solutions
Published on 11/06/2026 at 09:42, 1 hour ago Silver for the Thorium Pioneer: Emerald Horizon Takes Second Place at “Innovator of the Year” 2026
Published on 11/05/2026 at 18:21, 16 hours 21 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 17:45, 16 hours 58 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 11/05/2026 at 17:29, 17 hours 14 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN FR0010406082
Published on 11/05/2026 at 10:16, 1 day ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
